1.69
price up icon3.11%   0.08
 
loading
전일 마감가:
$1.61
열려 있는:
$1.61
하루 거래량:
8,846
Relative Volume:
0.06
시가총액:
$39.04M
수익:
$48.20M
순이익/손실:
$-35.05M
주가수익비율:
-1.0783
EPS:
-1.5673
순현금흐름:
$-13.02M
1주 성능:
+6.75%
1개월 성능:
-11.23%
6개월 성능:
-23.85%
1년 성능:
-50.89%
1일 변동 폭
Value
$1.5345
$1.72
1주일 범위
Value
$1.47
$1.7699
52주 변동 폭
Value
$1.06
$5.22

Celularity Inc Stock (CELU) Company Profile

Name
명칭
Celularity Inc
Name
전화
(908) 768-2170
Name
주소
170 PARK AVE, FLORHAM PARK
Name
직원
120
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CELU's Discussions on Twitter

CELU을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CELU
Celularity Inc
1.70 39.04M 48.20M -35.05M -13.02M -1.5673
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.11 124.91B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
595.31 60.05B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
603.99 35.88B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.09 29.83B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.14 24.58B 3.81B -644.79M -669.77M -6.24

Celularity Inc Stock (CELU) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-01-30 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2022-12-22 다운그레이드 Oppenheimer Outperform → Perform
2022-06-22 개시 H.C. Wainwright Buy
2022-04-06 다운그레이드 Truist Buy → Hold
2022-01-28 개시 Oppenheimer Outperform
2021-11-24 개시 Morgan Stanley Equal-Weight
모두보기

Celularity Inc 주식(CELU)의 최신 뉴스

pulisher
Apr 23, 2025

Celularity faces Nasdaq delisting over late filing By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Celularity faces Nasdaq delisting over late filing - Investing.com

Apr 23, 2025
pulisher
Apr 14, 2025

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

CMS Extends Medicare Coverage for Wound Care Products: Major Win for Skin Substitute Market - Stock Titan

Apr 14, 2025
pulisher
Apr 07, 2025

Revolutionary NK Cell Therapy Shows Promise in Cancer Treatment: New Research Reveals - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology - The Globe and Mail

Apr 04, 2025
pulisher
Mar 31, 2025

Celularity Delays Yearly Report Filing Amid Financial Challenges - TipRanks

Mar 31, 2025
pulisher
Mar 22, 2025

Celularity extends debt maturity, issues stock to investor By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 21, 2025

Celularity enters into standby equity purchase agreement with Ya Ii Pn -March 21, 2025 at 04:39 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Celularity enters into standby equity purchase agreement with Ya Ii Pn - TradingView

Mar 21, 2025
pulisher
Mar 17, 2025

Robust Growth in Regenerative Placental Cell Therapy Market - openPR.com

Mar 17, 2025
pulisher
Feb 28, 2025

Celularity receives FDA TRG recommendation letters for Natalin, Acelagraft - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

CELU Stock Touches 52-Week Low at $1.29 Amid Market Challenges - Investing.com Australia

Feb 28, 2025
pulisher
Feb 27, 2025

CELU Stock Touches 52-Week Low at $1.29 Amid Market Challenges By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

Celularity Enters Strategic Collaboration Agreement with BlueSphere Bio to Support Cell Therapy Manufacturing - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Celularity Secures Crucial FDA Pathway for Wound Care ProductsCan They Capture Share of $810M Market? - StockTitan

Feb 25, 2025
pulisher
Feb 24, 2025

Celularity inks manufacturing deal with BlueSphere Bio By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

Celularity inks manufacturing deal with BlueSphere Bio - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This New Cell Therapy Manufacturing Deal Transform Celularity's Revenue Potential? - StockTitan

Feb 24, 2025
pulisher
Feb 21, 2025

Celularity Inc.'s (NASDAQ:CELU) Business And Shares Still Trailing The Industry - Simply Wall St

Feb 21, 2025
pulisher
Feb 20, 2025

Celularity Inc. Extends Loan Agreements with Resorts World Inc and C.V. Starr & Co. - Defense World

Feb 20, 2025
pulisher
Feb 13, 2025

SEC Form FWP filed by Celularity Inc. - Quantisnow

Feb 13, 2025
pulisher
Feb 10, 2025

Celularity Inc (CELU) Stock: Analyzing the Market Value - The News Heater

Feb 10, 2025
pulisher
Feb 06, 2025

Celularity Inc (CELU) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Feb 06, 2025
pulisher
Feb 06, 2025

Placental Stem Cell Therapy Solution Market Size And Booming - openPR

Feb 06, 2025
pulisher
Feb 01, 2025

Celularity files to sell 6.52M shares of Class A common stock, warrants - MSN

Feb 01, 2025
pulisher
Jan 27, 2025

Celularity cancels material agreement with investor - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Celularity amends warrant terms, secures $2.46 million funding By Investing.com - Investing.com Canada

Jan 27, 2025
pulisher
Jan 27, 2025

Celularity amends warrant terms, secures $2.46 million funding - Investing.com India

Jan 27, 2025
pulisher
Jan 27, 2025

MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs - The Manila Times

Jan 27, 2025
pulisher
Jan 25, 2025

Celularity cancels material agreement with investor By Investing.com - Investing.com

Jan 25, 2025
pulisher
Jan 24, 2025

Celularity Faces Challenges as Agreement Expires - TipRanks

Jan 24, 2025
pulisher
Jan 21, 2025

Celularity Inc. (NASDAQ:CELU) Short Interest Up 7.1% in December - Defense World

Jan 21, 2025
pulisher
Jan 11, 2025

Celularity (NASDAQ:CELU) Shares Down 0.5% – Here’s What Happened - Defense World

Jan 11, 2025
pulisher
Jan 03, 2025

Amniotic Products Global Industry Report 2025: Growth in Regenerative Medicine Propels the Use of Amniotic Products in Tissue Repair and Healing - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Dec 22, 2024

**Celularity Inc. Holds Annual Meeting and Reports Voting Results** - Defense World

Dec 22, 2024
pulisher
Dec 10, 2024

CELUCelularity Inc. Latest Stock News & Market Updates - StockTitan

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity announces resolution of Nasdaq listing compliance matter - Nasdaq

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity Restores Nasdaq Compliance After Major Financial Reporting Overhaul - StockTitan

Dec 10, 2024
pulisher
Dec 07, 2024

Celularity reports Q3 EPS (73c) vs. ($4.98) last year - MSN

Dec 07, 2024
pulisher
Dec 06, 2024

Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145% - Nasdaq

Dec 06, 2024
pulisher
Dec 06, 2024

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - The Manila Times

Dec 06, 2024

Celularity Inc (CELU) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Celularity Inc 주식 (CELU) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hariri Robert J
Chief Executive Officer
Apr 13 '25
Option Exercise
0.00
3,281
0
21,482
Haines John R
Senior Exec Vice President
Apr 13 '25
Option Exercise
0.00
1,641
0
29,698
Beers David C
Chief Financial Officer
Apr 13 '25
Option Exercise
0.00
1,025
0
18,561
Brigido Stephen
Pres., Functional Regeneration
Feb 17 '25
Option Exercise
0.00
10,000
0
11,641
Beers David C
Chief Financial Officer
Feb 17 '25
Option Exercise
0.00
12,500
0
21,932
Haines John R
Senior Exec Vice President
Feb 17 '25
Option Exercise
0.00
20,000
0
35,092
$20.27
price up icon 0.35%
$67.24
price down icon 2.81%
$31.69
price down icon 0.93%
$33.23
price down icon 0.81%
$114.98
price down icon 0.20%
biotechnology ONC
$253.97
price up icon 0.51%
자본화:     |  볼륨(24시간):